DTI Phantom Validation for MRI Reliability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diffusion tensor imaging (DTI) systems face challenges in validating the quality of DTI data due to the lack of industry-accepted MRI phantoms that can accurately represent organized tissue structures, leading to difficulties in obtaining high-quality DTI images and comparing data across different machines and time points.

Innovation Solution

A computer-implemented method and system for analyzing MRI patient data using phantom data from MRI machines scanning specific DTI phantoms, which are designed to validate the accuracy of in-vivo measurements across time and vendors, generating metrics for assessing MRI performance and comparing them to previous metrics stored in a data library.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If DTI imaging is performed without industry-accepted validation phantoms, then clinical imaging can proceed with standard protocols, but the accuracy and reliability of DTI measurements cannot be validated across different machines and time points

Engineering Contradiction:
Improvereliability of DTI measurementsVSAvoidcomplexity of validation system
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent introduces a phantom as an intermediary object that mediates between the DTI imaging system and validation requirements. The phantom contains tissue-mimicking materials with known diffusion properties, allowing indirect validation of the imaging system without requiring direct measurement of actual tissue. This resolves the contradiction by providing a reliable validation mechanism while keeping the system relatively simple.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates simplified copies of actual tissue structures through phantom models that replicate the diffusion properties of biological tissues. These phantom copies allow validation of DTI measurements without requiring actual patient or animal tissue, enabling repeated, standardized validation across different imaging sessions and machines while maintaining reliability.

Inventive Principle:
Principle #26Copying

2Productivity

If DTI data is collected across different MRI machines and time points without standardized validation, then clinical throughput is maintained, but comparability and quality consistency of DTI data deteriorate

Engineering Contradiction:
Improveclinical imaging throughputVSAvoidprecision of DTI measurements
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent implements preliminary validation actions by scanning the phantom before actual patient imaging sessions. This preliminary scan establishes baseline performance metrics for each MRI machine, allowing operators to detect and correct potential issues before they affect patient data quality. This ensures measurement precision is maintained while allowing continuous clinical throughput.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent establishes a feedback mechanism where phantom scan results are compared against known reference values, and deviations are used to adjust or flag imaging parameters. This feedback loop ensures that DTI measurements maintain precision across different machines and time points while allowing high clinical throughput through automated quality control.

Inventive Principle:
Principle #23Feedback

3Measurement precision

If advanced DTI validation protocols are implemented, then measurement accuracy improves, but the time and resources required for validation increase

Engineering Contradiction:
Improveaccuracy of DTI measurementsVSAvoidtime for validation procedures
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent implements a tiered validation approach where essential phantom scanning is performed at minimum frequencies required for clinical operation, with optional more frequent or comprehensive validation available. This partial action approach maintains adequate measurement accuracy while minimizing time loss by performing only the necessary validation steps for routine clinical practice.

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The proposed solution enables the validation of DTI measurements across time and different machines, improving the reliability and comparability of DTI data, and facilitating the use of DTI in clinical applications by standardizing protocols and ensuring high-quality imaging.

Implementation Method 1

diffusion weighted imaging (DWI) measures the extent and direction of water diffusion through biological tissue

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

Magnetic Resonance Imaging (MR or MRI) are commonly used to identify certain disease conditions and pathologies

Methodology Applied
Scientific EffectMagnetic resonance imaging: Magnetic Field

Data Source

PatentUS20250107724A1Systems and methods for validating magnetic resonance imaging (MRI) machines and MRI data
Publication Date: 2025.04.03 PREOPERATIVE PERFORMANCE INC
  • US20250107724A1 patent drawing
  • US20250107724A1 patent drawing
  • US20250107724A1 patent drawing

AI summary

A computer-implemented method is provided for the purposes of validating patient data obtained from a magnetic resonance imaging (MRI) machine. The method involves receiving phantom data acquired from scanning a phantom, such as a diffusion tensor imaging (DTI) phantom, designed for the purposes of validating accuracy of in-vivo measurements, such as DTI relevant metrics, across time and vendor, and analyzing the phantom data to generate metrics for assessing MRI performance. Optionally, the MRI machine may be identified as a validated machine as part of the method by comparing the generated MRI metrics with previous metrics stored in a data library.